Series A funding roundup: Intellect, Cytovation, SeqOne Genomics, Kenbi, Amber Implants

The Netherlands: Amber Implants, a medical technology company developing next generation spinal implants, has closed a US$10m Series A Financing. The round was co-led by the founders and existing venture capital investors, with participation from angel investors and non-dilutive government funding. Funds will be used to advance its vertebral body augmentation system, VCFix, through all preclinical verification…

You must be a HMI Subscriber to view this content.

Subscribe Now »